News

Filter

Current filters:

None

82 to 91 of 98134 results

Sanofi and Zealand's Lyxumia not superior to placebo in cardiovascular safety Phase IIIb trial

Sanofi and Zealand's Lyxumia not superior to placebo in cardiovascular safety Phase IIIb trial

19-03-2015

French drug major Sanofi has announced top-line results from its Phase IIIb ELIXA study, comparing Lyxumia…

DiabetesLyxumiaPharmaceuticalResearchSanofiZealand Pharma

BIAL’s opicapone significantly improves OFF-time in fluctuating Parkinson’s

19-03-2015

Privately-held Portuguese drugmaker BIAL today announced positive results from a Phase III, randomized,…

BIALNeurologicalopicaponePharmaceuticalResearch

CCMD to become Malaysia’s largest pharmaceutical manufacturer

19-03-2015

CCM Duopharma Biotech Berhad (CCMD) looks set to become one of Malaysia’s largest pharmaceutical manufacturers…

CCM DuopharmaGenericsMalaysiaMergers & AcquisitionsProduction

FDA grants Nicox orphan drug designation for naproxcinod in Duchenne muscular dystrophy

FDA grants Nicox orphan drug designation for naproxcinod in Duchenne muscular dystrophy

19-03-2015

French ophthalmic specialist Nicox has been granted orphan drug designation by the US Food and Drug Administration…

GeneticsnaproxcinodNicOxNicOxRegulation

FDA approval for Vertex’ Kalydeco for very young children

18-03-2015

There was good news for US biotech firm Vertex Pharmaceuticals yesterday, when the US Food and Drug Administration…

BiotechnologyKalydecoRare diseasesRegulationUSAVertex Pharmaceuticals

UK Chancellor’s Budget Statement answers BIA’s calls on both SME access to R&D tax credits

18-03-2015

The UK BioIndustry Association (BIA) welcomes statements made in today’s Budget announced by UK Chancellor…

FinancialPharmaceuticalPoliticsUK

Zeltia poised for significant potential growth, Edison raises valuation

Zeltia poised for significant potential growth, Edison raises valuation

18-03-2015

Spanish pharma company Zeltia is laying the groundwork for a period of significant potential growth and…

Business FinanceOncologyPharmaceuticalSpainYondelisZeltia

Research from IQWiG shows early benefit assessment increases trial data transparency

Research from IQWiG shows early benefit assessment increases trial data transparency

18-03-2015

Research from the German Institute for Quality and Efficiency in Healthcare (IQWiG) published in the…

Efficiency in HealthcareGermanyPharmaceuticalPharmacologyRegulation

Genmab acquires antibody assets from iDD Biotech

18-03-2015

Danish biotech company Genmab has entered into an agreement to purchase antibodies and related patents…

BiotechnologyGenmabiDD BiotechMergers & AcquisitionsOncology

82 to 91 of 98134 results

Back to top